Document is current
Any future updates will be listed below
-
Authors
Kristensen, Signe Agnete Rønde https://orcid.org/0009-0003-0812-4075
Kvist-Hansen, Amanda https://orcid.org/0000-0002-0390-9151
Skov, Lone https://orcid.org/0000-0002-4784-9680
-
Funding
Funding for this research was provided by:
LEO Fondet (LF-ST-21-500002)
Novo Nordisk Fonden (NNF23SA0087869)
- License Information
-
More Information
Article History
Accepted: 31 July 2025
First Online: 16 August 2025
Declarations
:
: Dr. Kristensen and Dr. Kvist-Hansen declare no conflicts of interest. Dr. Skov has received research funding from Sanofi, Bristol-Myers Squibb, Almirall, Janssen, the Danish National Psoriasis Foundation, the LEO Foundation and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as consultant and/or speaker for AbbVie, Eli Lilly, Novartis, Pfizer, LEO Pharma, Janssen, UCB, Almirall, Bristol-Myers Squibb, UCB Stada Takeda, and Sanofi. She has served as an investigator for AbbVie, Pfizer, Sanofi, Janssen, Boehringer Ingelheim, AstraZeneca, Eli Lilly, Novartis, Regeneron, Galderma, and LEO Pharma.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All the authors participated equally in the drafting of the manuscript. All the authors read and approved the final paper.
